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INTRODUCTION
Understanding the contributions of hepatic glucose release to hyperglycemia following a meal is crucial
for gaining insight into insulin resistance (IR) and assessing novel therapies for metabolic disorders.
Using an oral glucose tolerance test (OGTT) protocol with two stable isotope tracers, both the rate of
appearance of exogenous glucose (Raexo) coming from the drink and the suppression of endogenous
glucose (Raendo)in response to the drink may be computed. In previous work, investigators have
proposed several different methods for computing the rate of appearance of exogenous glucose. The
aim of this project was to compare the implementation and results of these methods applied to OGTT
data from a cohort of obese adolescent girls. Obtaining a reliable estimate of the rate of appearance
of exogenous glucose represents a key input to differential equation based models of whole body
glucose-insulin dynamics used to quantify hepatic and muscle IR.
OGTT Study Design:
METHODS
Nonsteady State Model for Total Rate of Appearance of Glucose (Steele, Ann N Y Acad
Sci., 1959)
Uses mass balance equations for total glucose and tracer II to determine the rate of appearance of total
glucose, Ra:
Ra =





where F is the infusion rate of tracer II, pV is the volume of distribution, C is the concentration of
glucose and E is the enrichment of tracer II.
Clamp Model for Raexo (Kim et al., Nutr Metab, 2014)





where ED and EP are enrichments of tracer I from the test drink and plasma, respectively.
One Pool Model for Raexo (J. Proietto, Horm Metab Res Suppl, 1990)
Uses known total Ra and Steele’s non-steady state equation with tracer I to solve for F ; the variable
infusion rate of tracer I represents the rate of appearance of tracer I, Ra13C due to gut absorption. Ra13C
is scaled by the enrichment of tracer I in the drink to obtain Raexo:








where F2 is the appearance rate of tracer I in
plasma, E is the enrichment of tracer I and Ei is
the enrichment of tracer I in the drink., respec-
tively.
One Compartment Model for Raexo (Basu et al., Am J Physiol Endocrinol Metab, 2003)
Assumes one compartment model and uses mass balance equations for both tracers to determine Ra13C ;









where F2H is the infusion of tracer II, pV is the volume of distribution, G13C and G2H are the concentra-
tions of tracer I and tracer II in plasma, respectively.
CONCLUSIONS AND FUTURE WORK
The greatest variability among estimates of Raexo occurred in the first ~90 minutes following ingestion
of the test drink. This corresponds to the time period when the tracer I/tracer II ratio changes rapidly,
and it likely reflects differences among the methods in the handling of dynamic enrichments. These
methods also yield different rates and degrees of suppression of Raendo including non-physiologic neg-
ative Raendo values. A two-compartment model or a protocol using variable infusion of tracer II may
address this issue and will be investigated in future work.
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RESULTS
Results for Subject 10:
Time (min)





























































































Ratio of Tracer I to Tracer II
Time (min)
0 50 100 150 200 250 300 350 400
En
do
ge
no
us
 R
a 
(U
m
ol
/k
g/
m
in
)
-20
-10
0
10
20
30
40
50
Endogenous Ra
Kim
Pro
Basu
